Inhibition of autoimmune encephalomyelitis by a tetracycline. - Wikidata - awgldk - TriplyDB

Inhibition of autoimmune encephalomyelitis by a tetracycline.

Inhibition of autoimmune encephalomyelitis by a tetracycline.

http://www.wikidata.org/entity/Q34113359

about

Inhibition of p53 transcriptional activity: a potential target for future development of therapeutic strategies for primary demyelination Mechanisms and potential therapeutic applications of microglial activation after brain injury Role of microglia in CNS autoimmunity The yin and yang of microglia The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII Emerging therapies in multiple sclerosis.PEG minocycline-liposomes ameliorate CNS autoimmune disease.Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's disease Proton magnetic resonance spectroscopy reveals neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDS Alterations in CD200-CD200R1 System during EAE Already Manifest at Presymptomatic Stages.Minocycline is cytoprotective in human trabecular meshwork cells and optic nerve head astrocytes by increasing expression of XIAP, survivin, and Bcl-2.Minocycline protects against neurologic complications of rapid correction of hyponatremia.Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study.Improving outcomes of neuroprotection by minocycline: guides from cell culture and intracerebral hemorrhage in mice Minocycline causes widespread cell death and increases microglial labeling in the neonatal mouse brain.Matrix metalloproteinases, synaptic injury, and multiple sclerosis Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis.Reversible neural stem cell niche dysfunction in a model of multiple sclerosis.Minocycline reduces ethanol drinking.Disease-modifying therapies in multiple sclerosis: an update on recent and ongoing trials and future strategies.Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis Tetracycline suppresses ATP gamma S-induced CXCL8 and CXCL1 production by the human dermal microvascular endothelial cell-1 (HMEC-1) cell line and primary human dermal microvascular endothelial cells Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial Neural circuit architecture defects in a Drosophila model of Fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase Emerging disease modifying therapies for multiple sclerosis.Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons.Role of oral Minocycline in acute encephalitis syndrome in India - a randomized controlled trial.Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease Minocycline modulates neuroinflammation independently of its antimicrobial activity in staphylococcus aureus-induced brain abscess.Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.Minocycline as a neuroprotective agent.Minocycline counter-regulates pro-inflammatory microglia responses in the retina and protects from degeneration Traumatic injury to the immature brain: inflammation, oxidative injury, and iron-mediated damage as potential therapeutic targets.Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion.Minocycline: far beyond an antibiotic.Targeting MMPs in acute and chronic neurological conditions.Systemic infections in multiple sclerosis and experimental autoimmune encephalomyelitis.

P2860

Q24627168-1E7B1800-2952-4A94-8027-DECA52FBF75F Q26864358-2B12AB1B-CFA5-47E2-B7D7-74173EF1F697 Q27003940-3F2C5331-C23E-4990-BBCE-93ABA6B031EA Q27693871-19CB4EC5-81B3-422F-A3E2-2CBE5252A9F2 Q28299076-651E1533-8FC5-4FE8-B27A-5554E9B82CE9 Q28574259-AEA7AE69-E26E-45FE-BE9D-34C8887AEC96 Q28576309-AB7DF051-B39B-4005-AB20-91683A4CA525 Q31015100-FAFE0E2B-D964-45C3-A785-B38814D95C66 Q33398048-74FAA21B-2B6E-43E1-80F0-CC2C2F0DFEC4 Q33499111-FD98E247-02CB-46FB-9C49-231B8E69AB25 Q33580220-13A79BDF-9E1C-4953-B837-523B36ABC31E Q33634159-9E2902BC-44DF-403A-A665-4F17B96F57D8 Q34019667-4CBA82C7-CD18-49A0-B4B2-E73B1F06A899 Q34457158-1A09BFBF-45C5-4C12-BB18-DBB4FD15BB17 Q34543420-F540A1FD-AE31-47EC-A083-D67E2697687B Q34623345-74B17373-59CA-45C0-85D5-1F1BDBDD6F85 Q34659673-1E86E7F3-A2EB-462B-B6DA-0273488C8392 Q34679058-2EE9B65D-4806-4DD9-AED1-9F31B0A7ECB2 Q34689554-ECE7D307-862D-454E-A4BC-A91771998D41 Q34738778-ED61814F-27ED-4E4F-BB5D-E2F22A94D6C1 Q34861360-1315AEF6-BA50-4414-95BF-B8E19C717B24 Q34993419-E8AE2E88-8A8E-46D8-845E-10A37229CC35 Q35094706-23943439-9794-4262-B13A-6D0F46CD8761 Q35103843-FE4CD5C9-BCA3-464E-AA61-1F27633A7AFE Q35140699-EDACA6E1-6551-4841-A5A3-D5C8DEA2C645 Q35215604-CB3449A0-3FBD-460D-9DF1-838E72ED0B7F Q35232638-49CACEF1-5254-49A8-8354-8B646EC843CD Q35581158-98ED818D-6C56-4763-8763-4C61BD59CF03 Q35687315-F00A725A-8103-4D32-9824-957FAD2BF270 Q35914957-1CAF6845-DAF2-4751-BCC8-1CD8AE79408B Q35918549-46422C7D-5C34-40FC-9B29-37D8328BDD35 Q36007420-86E39B13-71FE-4806-A17D-C1BD21941C1F Q36153387-A6C6BE76-D65B-4D29-B8CF-2A6089C0CF46 Q36215217-69E91F9E-822B-499C-A89C-5C49B794B268 Q36294246-8F04B892-BB10-420C-A06A-DE8DC7DFAC78 Q36428733-46301B61-B79F-4346-B8E8-06917E2685FA Q36487440-E4E1DF0D-4A46-46DF-946D-BB7CEF214D52 Q36836358-65888EBB-DD33-4BD2-9357-EDB5785CA0E6 Q36963155-DFF355AD-24B8-4228-AA42-29113264947B Q36964570-F5AAD9AF-B844-455A-AAB2-A6A86DF9B6F5

P2860

Inhibition of autoimmune encephalomyelitis by a tetracycline.

http://www.wikidata.org/entity/Q34113359

description

2002 nî lūn-bûn

@nan

2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Inhibition of autoimmune encephalomyelitis by a tetracycline.

@ast

Inhibition of autoimmune encephalomyelitis by a tetracycline.

@en

Inhibition of autoimmune encephalomyelitis by a tetracycline.

@nl

type

label

Inhibition of autoimmune encephalomyelitis by a tetracycline.

@ast

Inhibition of autoimmune encephalomyelitis by a tetracycline.

@en

Inhibition of autoimmune encephalomyelitis by a tetracycline.

@nl

prefLabel

Inhibition of autoimmune encephalomyelitis by a tetracycline.

@ast

Inhibition of autoimmune encephalomyelitis by a tetracycline.

@en

Inhibition of autoimmune encephalomyelitis by a tetracycline.

@nl

P1433

Q34113359-158392F9-E2E3-4B06-A06C-ADFE255B7D35

P1476

Q34113359-99DD93C5-0805-4CE8-9F22-669ADD68794C

P2093

Q34113359-6EAEF527-C591-424B-9C32-B15F6B4A8CB6

Q34113359-70D0FEFC-2DA6-4F2A-99E8-87B3A4B86090

Q34113359-D2E0E00B-BBBD-4517-BDBF-031018D269E3

Q34113359-DEDAAF25-1068-407C-94B1-64770C11A3BD

Q34113359-F51A6A06-8EB0-4F32-B751-770244EBD585

P2860

Q34113359-09AE216D-0B7B-4F23-B79C-9E590624C786

Q34113359-0DD5A684-AED8-4209-8124-0590B05FD777

Q34113359-12083BB9-2EB6-4332-97DE-F9617631240F

Q34113359-16495D1B-E008-423F-94B5-0D6BD7AB5BCE

Q34113359-23D11205-EFE0-4CBD-BA74-700EB4EB8FE4

Q34113359-303DB691-F54E-4C04-BE12-0E30A8E7A35C

Q34113359-4945DB06-3042-4604-817F-5817F9BA9B18

Q34113359-4998C74F-F7FF-438D-A481-82397A0D1E69

Q34113359-5D5E354F-7EDC-4E54-8401-A538129A54C6

Q34113359-5E33C560-2554-4B8D-AE30-104666F9705A

P304

Q34113359-EF73ABC9-111C-489B-8B72-EAD9B8CE1A84

P31

Q34113359-999E34CF-80D9-4510-8BB5-38C5C69DAAE8

P356

Q34113359-6D95465C-7D30-47B7-ADCD-25E008EFB63D

P433

Q34113359-EF8A6581-F445-4B84-8160-29DB98A034F4

P478

Q34113359-FDF42E89-6349-4D77-9DF8-24FF584ED0F6

P50

Q34113359-51797D2E-7558-406E-A6AB-4E6236FE0D87

P577

Q34113359-A0B399D8-517D-4AC8-A802-9B92E36CA6C5

P5875

Q34113359-1B777CA9-8C9D-4FE5-A175-A1F34FC251C6

P698

Q34113359-ABA11880-75A9-4CA0-85E6-A40C62EA7B55

P356

P1433

Annals of Neurology

P1476

Inhibition of autoimmune encephalomyelitis by a tetracycline

@en

P2093

Anna Schubart

http://www.w3.org/2001/XMLSchema#string

Brian D Goetz

http://www.w3.org/2001/XMLSchema#string

Ian D Duncan

http://www.w3.org/2001/XMLSchema#string

Natalija Popovic

http://www.w3.org/2001/XMLSchema#string

Su-Chun Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia

Axonal transection in the lesions of multiple sclerosis

Interleukin-10 is an unequivocal Th2 parameter in the rat, whereas interleukin-4 is not.

Microglia as mediators of inflammatory and degenerative diseases.

Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia

Progress in determining the causes and treatment of multiple sclerosis.

Matrix metalloproteinases in inflammatory demyelination: targets for treatment.

The link between excitotoxic oligodendroglial death and demyelinating diseases.

Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.

A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window

P304

215-223

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.10092

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

Christopher Linington

P577

2002-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11526186

http://www.w3.org/2001/XMLSchema#string

P698

11835378

http://www.w3.org/2001/XMLSchema#string